secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADC Therapeutics SA (ADCT)
CIK:        0001771910
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0000950103-24-003156
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADC Therapeutics SA Board approves Annual Bonus Plan for 2024
-------------------------------------------------------------

- Plan effective retroactively from Jan 1, 2024; bonuses based on corporate objectives approved by Board or Compensation Committee.
- Eligible participants: full-time and part-time regular employees in good standing, including named executive officers.
- Target bonus expressed as percentage of base salary; payout determined after year-end per payout curve for each objective.
- Payment to be made on or before March 15 (US) or end of March (other countries); prorated for new hires, transfers, leaves.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/0000950103-24-003156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1771910/000095010324003156/dp207290_8k.htm
  HTML page:      https://secwatch.observer/filing/0000950103-24-003156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer